ADJUVANT CHEMOTHERAPY AND RADIATION IN PATIENTS WITH POOR PROGNOSTIC STAGE-IB/IIA CERVICAL-CANCER

被引:26
作者
KILLACKEY, MA
BOARDMAN, L
CARROLL, DS
机构
[1] COLUMBIA UNIV,ST LUKES ROOSEVELT HOSP CTR,DEPT OBSTET & GYNECOL,NEW YORK,NY 10019
[2] COLUMBIA UNIV,ST LUKES ROOSEVELT HOSP CTR,DEPT MED,NEW YORK,NY 10019
关键词
D O I
10.1006/gyno.1993.1143
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
After radical hysterectomy and pelvic lymphadenectomy, 35 women with multiple negative prognostic factors (nodal metastases, stromal invasion >65%, parametrial extension, positive surgical margins, lymphovascular involvement, lesion size >4 cm, and adenosquamous or poorly differentiated cancers) were offered adjuvant therapy. Thirteen patients (37.1%) received radiation alone and 22 (62.9%) were treated with a platinum-based regimen of chemotherapy and radiotherapy. In the group receiving radiation, 2 (14.3%) had recurrences. In the 22 women treated with both modalities, there have been no recurrences with a mean follow-up time of 37.1 months. The results in the combined modality group were encouraging given the fact that these women had on average 3.5 poor prognostic features compared to the radiotherapy group where there was an average of 2.2 high-risk factors. © 1993 Academic Press, Inc.
引用
收藏
页码:377 / 379
页数:3
相关论文
共 16 条
[1]  
BEREK JS, 1985, OBSTET GYNECOL, V65, P46
[2]  
BUXTON EJ, 1990, CANCER CHEMOTHER S17, V26, P17
[3]   CERVIX CARCINOMA - TREATMENT WITH COMBINATION CISPLATIN AND BLEOMYCIN [J].
DAGHESTANI, AN ;
HAKES, TB ;
LYNCH, G ;
LEWIS, JL .
GYNECOLOGIC ONCOLOGY, 1983, 16 (03) :334-339
[4]  
HOGAN WM, 1982, CANCER-AM CANCER SOC, V49, P1278, DOI 10.1002/1097-0142(19820315)49:6<1278::AID-CNCR2820490634>3.0.CO
[5]  
2-R
[6]  
JOBSON VW, 1980, SURG GYNECOL OBSTET, V151, P27
[7]  
LAHOUSEN M, 1990, ZBL GYNAKOL, V112, P707
[8]   ADJUVANT CHEMOTHERAPY AFTER RADICAL HYSTERECTOMY FOR CERVICAL-CARCINOMA [J].
LAI, CH ;
LIN, TS ;
SOONG, YK ;
CHEN, HF .
GYNECOLOGIC ONCOLOGY, 1989, 35 (02) :193-198
[9]   CONCURRENT RADIATION-THERAPY, CIS-PLATINUM, AND MITOMYCIN-C IN PATIENTS WITH POOR PROGNOSIS CANCER OF THE CERVIX - A PILOT-STUDY [J].
MALVIYA, VK ;
DEPPE, G ;
KIM, Y ;
GOVE, N .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (05) :434-437
[10]  
MORROW CP, 1980, GYNECOL ONCOL, V10, P105, DOI 10.1016/0090-8258(80)90071-2